Author: Dato Dr. Kim TanDato Dr. Kim Tan is the founder Chairman of SpringHill Management Ltd (UK), a fund management company in biotech and social venture capital investments. Dato Kim is the Chairman of the NCI Cancer Hospital (Malaysia) and a board director of a number of companies in Malaysia, India, the UK, South Africa, and the USA. He is an advisor to a number of government agencies in Asia on biotechnology and is a board member of the Asia Pacific Economic Cooperation (APEC) Life Science Forum. He is the Chairman of the West Surrey & North Hants Innovation and Growth Team (UK). He has a Ph.D. in biochemistry and is the inventor of sheep monoclonal antibodies and a Fellow of the Royal Society of Medicine. He is the co-founder of Transformational Business Network, the UK charity with social transformational businesses in developing countries, including the Kuzuko Game Reserve in South Africa and the Hagar Social Enterprise Group in Cambodia.